Patent assignee · US · COMPANY

Sangart, Inc.

12Patents
8Active
12Granted
41Portfolio score

Filing activity: Jul 20, 2001 → Sep 1, 2011 · 6 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US6844317B2 Methods for oxygen transport comprising a high oxygen affinity modified hemoglobin Human Necessities 31 Expired
US6974795B2 Compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin Human Necessities 16 Expired
US6773613B1 Method for production of stroma-free hemoglobin Emerging Cross-Sectional Technologies 15 Expired
US7625862B2 Method for making a high oxygen affinity modified hemoglobin for oxygen transport Chemistry; Metallurgy 13 Active
US7989414B2 Compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin Chemistry; Metallurgy 8 Active
US8377868B2 Compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin Chemistry; Metallurgy 6 Active
US7271145B2 Methods and compositions for oxygen transport comprising modified hemoglobin in plasma Human Necessities 4 Expired
US8021858B2 Method for making polyalkylene oxide modified hemoglobin Human Necessities 2 Active
US9493616B2 Methods for preparing PEG-hemoglobin conjugates using reduced reactant ratios Human Necessities 1 Active
US7622439B2 Method to enhance hemodynamic stability using oxygen carrying compositions Human Necessities 1 Active
US8278275B2 Method to enhance hemodynamic stability using oxygen carrying compositions Human Necessities 1 Active
US8609815B2 Methods for preparing stable deoxygenated PEG-hemoglobin conjugate solutions comprising an antioxidant Chemistry; Metallurgy 1 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.